Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab

Atezolizumab and bevacizumab combination therapy might be one of the treatment options for hepatocellular carcinoma concurrent with gastric adenocarcinoma.

Detalles Bibliográficos
Autores principales: Suga, Takayoshi, Kimura, Yuko, Furuya, Kensuke, Sato, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483490/
https://www.ncbi.nlm.nih.gov/pubmed/37692146
http://dx.doi.org/10.1002/ccr3.7875
Descripción
Sumario:Atezolizumab and bevacizumab combination therapy might be one of the treatment options for hepatocellular carcinoma concurrent with gastric adenocarcinoma.

Ejemplares similares